SECUKINUMAB DEMONSTRATES CONSISTENT SAFETY OVER LONG-TERM EXPOSURE (UP TO 3 YEARS) IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF THREE PHASE 3 STUDIES

被引：0
|
作者：
Deodhar, A. [1 ]
Baraliakos, X. [2 ]
Marzo-Ortega, H. [3 ,4 ]
Sieper, J. [5 ]
Gupta, A. D. [6 ]
Porter, B. [7 ]
Fox, T. [8 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Ruhr Univ Bochum, Bochum, Germany
[3] Univ Leeds, Leeds Teaching Hosp Trust, Leeds, W Yorkshire, England
[4] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[5] Charite, Berlin, Germany
[6] Novartis Healthcare, Hyderabad, India
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Novartis Pharma AG, Basel, Switzerland
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
174
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [21] Secukinumab Demonstrates Rapid and Sustained Efficacy in Ankylosing Spondylitis Patients with Normal or Elevated Baseline CRP Levels: Pooled Analysis of Two Phase 3 Studies
    Braun, Juergen
    Sieper, Joachim
    Landewe, Robert B. M.
    Baraliakos, Xenofon
    Miceli-Richard, Corinne
    Martin, Ruvie
    Porter, Brian
    Gandhi, Kunal
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [22] Cardio-metabolic effects of long-term treatment with secukinumab in psoriatic arthritis and ankylosing spondylitis patients: Pooled 3 year analysis
    McInnes, Iain B.
    Gladman, Dafna D.
    Deodhar, Atul A.
    Miceli-Richard, Corinne
    Nash, Peter
    Sattar, Naveed
    Mehta, Nehal N.
    Wang, Jianyuan
    Pricop, Luminita
    di Comite, Gabriele
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB33 - AB33
  • [23] Consistent Safety and Tolerability of Secukinumab over Long-Term Exposure in Patients with Active Psoriatic Arthritis and Moderate to Severe Plaque Psoriasis: Updated Pooled Safety Analyses
    Mease, Philip J.
    McInnes, Iain B.
    Reich, Kristian
    Andersson, Mats
    Tao, Aiyang
    Fox, Todd
    Karyekar, Chetan
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [24] CONSISTENT SAFETY AND TOLERABILITY OF SECUKINUMAB OVER LONG-TERM EXPOSURE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND MODERATE TO SEVERE PLAQUE PSORIASIS: UPDATED POOLED SAFETY ANALYSES
    Mease, Philip J.
    McInnes, Iain B.
    Reich, Kristian
    RHEUMATOLOGY, 2017, 56 : 78 - 79
  • [25] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES
    Schett, Georg
    Baraliakos, Xenofon
    van den Bosch, Filip
    Deodhar, Atul
    Gensler, Lianne S.
    Ostergaard, Mikkel
    Agawane, Shital
    Das Gupta, Ayan
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Shete, Abhijit
    Porter, Brian
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 873 - 874
  • [26] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES
    Barkham, Nick
    Schett, Georg
    Baraliakos, Xenofon
    van den Bosch, Filip
    Deodhar, Atul
    Gensler, Lianne S.
    Ostergaard, Mikkel
    Agawane, Shital
    Gupta, Ayan Das
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Shete, Abhijit
    Porter, Brian
    RHEUMATOLOGY, 2020, 59
  • [27] Reduction in fatigue in patients with active ankylosing spondylitis: results of two phase 3 studies of secukinumab
    Kvien, T. K.
    Conaghan, P.
    Deodhar, A.
    Gossec, L.
    Ostergaard, M.
    Canete, J.
    Gandhi, K.
    Richards, H.
    Williams, N.
    Jugl, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 35 - 36
  • [28] REDUCTION IN FATIGUE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF TWO PHASE 3 STUDIES OF SECUKINUMAB
    Kvien, T. K.
    Conaghan, P. G.
    Deodhar, A.
    Gossec, L.
    Ostergaard, M.
    Canete, J.
    Gandhi, K.
    Richards, H.
    Williams, N.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 823 - 823
  • [29] EFFECT OF LONG-TERM TREATMENT WITH SECUKINUMAB ON LIPID PROFILE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: POOLED 4 YEAR ANALYSIS
    McInnes, Iain
    Gladman, Dafna D.
    Deodhar, Atul
    Richard, Corinne Miceli
    Nash, Peter
    Shete, Abhijit
    Asquith, Daren
    Richards, Hanno
    Pricop, Luminita
    Wang, Jianyuan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 886 - 887
  • [30] ASAS, BASDAI AND ASDAS REMISSION IN SECUKINUMAB TREATED PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A POOLED ANALYSIS OF TWO PHASE 3 STUDIES
    Baraliakos, X.
    Van den Bosch, F.
    Machado, P.
    Gensler, L.
    Bintu, S.
    Porter, B.
    Gaillez, C.
    Deodhar, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 743 - 743
12345